Paques Biomaterials is a biotechnology research company that produces and sells PHA (Polyhydroxyalkanoaat) from industrial and municipal waste streams. They use organic side streams to create a biobased and biodegradable alternative to plastic called Caleyda®. Their technology involves training natural microbes to produce PHA from waste streams, creating a fully natural and biodegradable alternative to plastic. The company aims to prevent plastic pollution and microplastics by offering a circular and valuable solution.

Paques Biomaterials

Produce and sell PHA from industrial and municipal waste streams

Great to see that our partners are as passionate about Caleyda as we are! 

#BoldPassion #BoldCooperation

📣 We are looking for a Chief Financial Officer who will guide the company’s financial strategy to secure its current and future growth so we can develop our circular chain to produce a natural alternative to plastic.

This is why we are developing Caleyda, the natural alternative to plastic.

Richard Schrama is showing our brand Caleyda® at the European Bioplastics Conference in Berlin. Caleyda® is PHA produced from organic side streams. It is a natural alternative to plastic with its advantages but without its disadvantages.

#EBC23 #EUBP #PHA

We will attend the EUBP conference and the exhibition! You will find Richard Schrama at our tabletop in the voyer and he will tell you all about Caleyda, our PHA brand. Hope to see you in Berlin!

👏 Van harte gefeliciteerd, Zuivere koffie, met het winnen van De Beste Overheidsinnovatie 2023! We hebben een mooie avond gehad met elkaar.
We vinden het dan ook een eer dat we genomineerd waren met het project PHA2USE waarin wij samenwerkten met de projectpartners:

Waterschap Brabantse Delta
Waterschap De Dommel
Waterschap Scheldestromen
Waterschap Hollandse Delta
Wetterskip Fryslân
HVC
AquaMinerals B.V.
Stichting Toegepast Onderzoek Waterbeheer STOWA

📣 News Flash: Paques Biomaterials and Looop partner in producing PHA!

"The cooperation with Looop offers us a secure supply of side streams to produce PHA from," says René Rozendal, co-founder of Paques Biomaterials. "Looop has a lot of experience in valorising side streams."

"We guarantee our suppliers the highest valorisation for their side streams," says Kelly Vermeer 🌍, manager of Procurement & Development at Looop. "Producing PHA provides higher valorisation, which ensures lower CO2 emissions and is for that reason an important broadening within our application areas. It is both biobased and circular and fits perfectly with our mission and vision."

"We have a very strong focus on partnerships. Our whole company is founded on collaborations and connection," says Paul Slits, the shareholder of Looop. There is no other way when you are in a circular chain."

Proud to be called one of the drivers of circular transition. René Rozendal is speaking at this event. Are you attending?

Thanks to João Sousa from Paques Biomaterials  (the netherlands) to come to IE University. Beautiful explanation on how to convert wastewater to bioplastics via PHA producing microorganisms. A win- win technology.
Juan Carlos Silva-Tamayo 
Carme Huguet

Metric
Company Name	Paques Biomaterials
Symbol
MSH ID	NL:PAQUESBIOMATERIALS
Market	PRIVATE
Sector	Waste Management
Industry	Biotechnology Research
Country	NL
Stage
Employee Count	12
Website	paquesbiomaterials.nl
LinkedIn	paques-biomaterials
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	6.74
28-Day Growth Score	12.02
90-Day Growth Score	57.65
365-Day Growth Score	33.56

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

NL:PAQUESBIOMATERIALS

Paques Biomaterials

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue